Table 1. Strain characteristics.
| Strain | City (country) | Year | Specimen | EU Clone* | Outbreak† | MDR‡ | |
| A. baumannii | |||||||
| UH875 | Dordrecht | (NL) | 1984 | urine | I | + | + |
| RUH134 | Rotterdam | (NL) | 1982 | urine | II | + | + |
| LUH5875 | Utrecht | (NL) | 1997 | blood | III | + | + |
| LUH8326 | Leiden | (NL) | 2002 | wound | - | − | − |
| RUH3023T (ATCC19606T) | Atlanta | (USA) | 1965 | urine | - | − | − |
| A. junii | |||||||
| LUH5851 | Leiden | (NL) | 1999 | ear | - | − | − |
*Strain belonging to European clones I–III (+) or not belonging to these clones (−). All isolates have been identified to species by one or more genotypic methods [1], [33], [34].
†
Outbreak-associated (+) strain (i.e., common AFLP profile in >2 patients and with same time-space-origin) or (−) sporadic strain.
‡
Multidrug-resistant (+) strain (i.e., resistant to more than two of the following drug classes or combinations: cephalosporins, carbapenems, ampicillin-sulbactam, quinolones and aminoglycosides) or (−) susceptible strain.